In 2006, Meunier et al. demonstrated that galantamine protects against Aβ-induced memory deficits partly by inhibiting AChE activity in the hippocampus at 7 days after Aβ25–35-induced AD [106]. This evidence concerns the gene ACHE and Alzheimer disease.